|
1
|
Hamadani M: Autologous hematopoietic cell
transplantation: An update for clinicians. Ann Med. 46:619–632.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Vincent Rajkumar S: Multiple myeloma: 2014
Update on diagnosis, risk-stratification, and management. Am J
Hematol. 89:999–1009. 2014.PubMed/NCBI
|
|
3
|
Hubel K, de la Rubia J, Azar N and
Corradini P: Current status of haematopoietic autologous stem cell
transplantation in lymphoid malignancies: A european perspective.
Eur J Haematol. 94:12–22. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Swerdlow SH, Campo E, Harris NL, Jaffe ES,
Pileri SA, Stein H and Thiele J: WHO classification of tumours of
haematopoietic and lymphoid tissues. Lyon, France: IARC Press;
2008
|
|
5
|
Gasová Z, Marinov I, Hrubá A, Benesová K
and Turek P: The efficiency of PBPC collections and the
relationship to the precollection concentration of CD 34+ cells in
blood. Transfus Sci. 20:181–188. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pozotrigo M, Adel N, Landau H, Lesokhin A,
Lendvai N, Chung DJ, Chimento D, Riedel E, Chen X, Reich L, et al:
Factors impacting stem cell mobilization failure rate and
efficiency in multiple myeloma in the era of novel therapies:
Experience at memorial sloan kettering cancer center. Bone Marrow
Transplant. 48:1033–1039. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hoggatt J, Speth JM and Pelus LM: Concise
review: Sowing the seeds of a fruitful harvest: Hematopoietic stem
cell mobilization. Stem cells. 31:2599–2606. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pusic I, Jiang SY, Landua S, Uy GL, Rettig
MP, Cashen AF, Westervelt P, Vij R, Abboud CN, Stockerl-Goldstein
KE, et al: Impact of mobilization and remobilization strategies on
achieving sufficient stem cell yields for autologous
transplantation. Biol Blood Marrow Transplant. 14:1045–1056. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gertz MA, Wolf RC, Micallef IN and
Gastineau DA: Clinical impact and resource utilization after stem
cell mobilization failure in patients with multiple myeloma and
lymphoma. Bone Marrow Transplant. 45:1396–1403. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dreger P, Haferlach T, Eckstein V, Jacobs
S, Suttorp M, Löffler H, Müller-Ruchholtz W and Schmitz N:
G-CSF-mobilized peripheral blood progenitor cells for allogeneic
transplantation: Safety, kinetics of mobilization, and composition
of the graft. Br J Haematol. 87:609–613. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Petit I, Szyper-Kravitz M, Nagler A, Lahav
M, Peled A, Habler L, Ponomaryov T, Taichman RS, Arenzana-Seisdedos
F, Fujii N, et al: G-CSF induces stem cell mobilization by
decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol.
3:687–694. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Salvucci O, Jiang K, Gasperini P, Maric D,
Zhu J, Sakakibara S, Espigol-Frigole G, Wang S and Tosato G:
MicroRNA126 contributes to granulocyte colony-stimulating
factor-induced hematopoietic progenitor cell mobilization by
reducing the expression of vascular cell adhesion molecule 1.
Haematologica. 97:818–826. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shaughnessy P, Uberti J, Devine S, Maziarz
RT, Vose J, Micallef I, Jacobsen E, McCarty J, Stiff P, Artz A, et
al: Plerixafor and G-CSF for autologous stem cell mobilization in
patients with NHL, Hodgkin's lymphoma and multiple myeloma: Results
from the expanded access program. Bone Marrow Transplant.
48:777–781. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Abhyankar S, DeJarnette S, Aljitawi O,
Ganguly S, Merkel D and McGuirk J: A risk-based approach to
optimize autologous hematopoietic stem cell (HSC) collection with
the use of plerixafor. Bone Marrow Transplant. 47:483–487. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sugrue MW, Williams K, Pollock BH, Khan S,
Peracha S, Wingard JR and Moreb JS: Characterization and outcome of
‘hard to mobilize’ lymphoma patients undergoing autologous stem
cell transplantation. Leuk Lymphoma. 39:509–519. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rossi G, Skert C, Morello E, Almici C,
Arcaini L, Basilico C, Cavalli L, Botto B, Castelli A, Pica G, et
al: PBSC mobilization in lymphoma patients: Analysis of risk
factors for collection failure and development of a predictive
score based on the kinetics of circulating CD34+ cells and WBC
after chemotherapy and G-CSF mobilization. Hematol Oncol.
33:125–132. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cooper DL, Medoff E, Patel N, Baker J,
Pratt K, Foss F, Seropian SE, Perreault S and Wu Y: Autologous stem
cell mobilization in the age of plerixafor. Clin Lymphoma Myeloma
Leuk. 16:411–416. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Teusink A, Vinks A, Zhang K, Davies S,
Fukuda T, Lane A, Nortman S, Kissell D, Dell S, Filipovich A and
Mehta P: Genotype-directed dosing leads to optimized voriconazole
levels in pediatric patients receiving hematopoietic stem cell
transplantation. Biol Blood Marrow Transplant. 22:482–486. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tuchman SA, Bacon WA, Huang LW, Long G,
Rizzieri D, Horwitz M, Chute JP, Sullivan K, Morris Engemann A,
Yopp A, et al: Cyclophosphamide-based hematopoietic stem cell
mobilization before autologous stem cell transplantation in newly
diagnosed multiple myeloma. J Clin Apher. 30:176–182. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Calderon-Cabrera C, Carmona Gonzalez M,
Martin J, Ríos Herranz E, Noguerol P, De la Cruz F, Carrillo E,
Falantes JF, Parody R, Espigado I, et al: Intermediate doses of
cytarabine plus granulocyte-colony-stimulating factor as an
effective and safe regimen for hematopoietic stem cell collection
in lymphoma patients with prior mobilization failure. Transfusion.
55:875–879. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xia W, Ma CK, Reid C, Bai L, Wong K,
Kerridge I, Ward C and Greenwood M: Factors determining pbsc
mobilization efficiency and nonmobilization following ICE with or
without rituximab (R-ICE) salvage therapy for refractory or
relapsed lymphoma prior to autologous transplantation. J Clin
Apher. 29:322–330. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ozkan HA, Bal C and Gulbas Z:
Chemomobilization with high-dose etoposide and G-CSF results in
effective and safe stem cell collection in heavily pretreated
lymphoma patients: Report from a single institution study and
review. Eu J Haematol. 92:390–397. 2014. View Article : Google Scholar
|
|
23
|
Re A, Cattaneo C, Skert C, Balsalobre P,
Michieli M, Bower M, Ferreri AJ, Hentrich M, Ribera JM, Allione B,
et al: Stem cell mobilization in HIV seropositive patients with
lymphoma. Haematologica. 98:1762–1768. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Clark RE, Bell J, Clark JO, Braithwaite B,
Vithanarachchi U, McGinnity N, Callaghan T, Francis S and Salim R:
Plerixafor is superior to conventional chemotherapy for first-line
stem cell mobilisation, and is effective even in heavily pretreated
patients. Blood Cancer J. 4:e2552014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sancho JM, Morgades M, Grifols JR, Juncà
J, Guardia R, Vives S, Ferrà C, Batlle M, Ester A, Gallardo D, et
al: Predictive factors for poor peripheral blood stem cell
mobilization and peak CD34(+) cell count to guide pre-emptive or
immediate rescue mobilization. Cytotherapy. 14:823–829. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lee KH, Jung SK, Kim SJ, Jang JH, Kim K,
Kim WS, Jung CW, Kim DW and Kang ES: Incidence and risk factors of
poor mobilization in adult autologous peripheral blood stem cell
transplantation: A single-centre experience. Vox Sang. 107:407–415.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kumar S, Dispenzieri A, Lacy MQ, Hayman
SR, Buadi FK, Gastineau DA, Litzow MR, Fonseca R, Roy V, Rajkumar
SV and Gertz MA: Impact of lenalidomide therapy on stem cell
mobilization and engraftment post-peripheral blood stem cell
transplantation in patients with newly diagnosed myeloma. Leukemia.
21:2035–2042. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Watts MJ, Ings SJ, Flynn M, Dodds D,
Goldstone AH and Linch DC: Remobilization of patients who fail to
achieve minimal progenitor thresholds at the first attempt is
clinically worthwhile. Br J Haematol. 111:287–291. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Russell N, Douglas K, Ho AD, Mohty M,
Carlson K, Ossenkoppele GJ, Milone G, Pareja MO, Shaheen D,
Willemsen A, et al: Plerixafor and granulocyte colony-stimulating
factor for first-line steady-state autologous peripheral blood stem
cell mobilization in lymphoma and multiple myeloma: Results of the
prospective PREDICT trial. Haematologica. 98:172–178. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Duarte RF, Shaw BE, Marin P, Kottaridis P,
Ortiz M, Morante C, Delgado J, Gayoso J, Goterriz R,
Martínez-Chamorro C, et al: Plerixafor plus granulocyte CSF can
mobilize hematopoietic stem cells from multiple myeloma and
lymphoma patients failing previous mobilization attempts: EU
compassionate use data. Bone Marrow Transplant. 46:52–58. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Arcaini L, Laszlo D, Rizzi S, Balzarotti
M, Antoniazzi F, Zilioli VR, Guggiari E, Farina L, Todisco E,
Bonfichi M, et al: Plerixafor and G-CSF for PBSC mobilization in
patients with lymphoma who failed previous attempts with G-CSF and
chemotherapy: A REL (Rete Ematologica Lombarda) experience.
Leukemia Res. 35:712–714. 2011. View Article : Google Scholar
|
|
32
|
Keating GM: Plerixafor: A review of its
use in stem-cell mobilization in patients with lymphoma or multiple
myeloma. Drugs. 71:1623–1647. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ikeda K, Kozuka T and Harada M: Factors
for PBPC collection efficiency and collection predictors. Transfus
Apher Sci. 31:245–259. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Perea G, Sureda A, Martino R, Altés A,
Martínez C, Cabezudo E, Amill B, Martín-Henao GA, González Y, Muñoz
L, et al: Predictive factors for a successful mobilization of
peripheral blood CD34+ cells in multiple myeloma. Annals Hematol.
80:592–597. 2001. View Article : Google Scholar
|
